Mitral Valve Aneurysm in Mitral Valve Endocarditis: A Case Report

Samuel J. Apple¹, Benjamin Ramalanjaona¹, Malicki Zorom² and Hamma Yacouba²

¹Division of Cardiovascular Diseases and Department of Internal Medicine, State University of New York, Downstate Medical Center, Health Sciences University, Brooklyn NY 11203, USA

²International Institute for Water and Environmental Engineering, 01 P.O. BOX poisson@594, Ouagadougou, Burkina Faso

Cite this paper

Samuel J. Apple, Benjamin Ramalanjaona, Malicki Zorom and Hamma Yacouba. Mitral Valve Aneurysm in Mitral Valve Endocarditis: A Case Report. American Journal of Medical Case Reports. 2020; 8(3):83-87. doi: 10.12691/AJMCR-8-3-5

Abstract

Mitral valve aneurysm (MVA) is an ominous complication of infective endocarditis (IE), with worse outcomes seen among patients with preexisting valvular disease or intravenous drug use. Valve aneurysms can perforate or lead to rupture of the chordae tendineae, with the consequent development of severe mitral regurgitation and acute pulmonary edema. We present a case of a 54-year-old woman with hypertension, obesity, diabetes mellitus, hyperlipidemia, chronic obstructive pulmonary disease, peptic ulcer disease, obstructive sleep apnea, gastroesophageal reflux disease, intravenous drug abuse and bipolar disorder who developed MVA one month after being discharged for IE. Decline in the clinical status of patients with IE is a troubling sign that may indicate an IE complication such as MVA. Physicians should diligently monitor patients with IE for changes in signs and symptoms, as early recognition and surgical intervention are key to prevent further morbidity and mortality.

Keywords

mitral valve aneurysm, infective endocarditis, infective endocarditis risk factors, surgical indications in infective endocarditis, post-pericardiotomy syndrome

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	McDonald JR. Acute infective endocarditis. Infectious disease clinics of North America. 2009 Sep 1; 23(3): 643-64.
[2]	Reid CL, Chandraratna AN, Harrison E, Kawanishi DT, Chandrasoma P, Nimalasuriya A, Rahimtoola SH. Mitral valve aneurysm: clinical features, echocardiographic-pathologic correlations. J Am Coll Cardiol. 1983; 2(3): 460-4.
[3]	Saphir O, Leroy EP. True aneurysms of the mitral valve in subacute bacterial endocarditis. Am J Pathol. 1948; 24(1): 83-95.
[4]	Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, Bruun NE, Høfsten DE, Fursted K, Christensen JJ, Schultz M. Partial oral versus intravenous antibiotic treatment of endocarditis. New England Journal of Medicine. 2019 Jan 31; 380(5): 415-24.
[5]	Guler A, Karabay CY, Gursoy OM, Guler Y, Candan O, Akgun T, Bulut M, Pala S, Izgi AI, Esen AM, Kirma C. Clinical and echocardiographic evaluation of mitral valve aneurysms: a retrospective, single center study. The international journal of cardiovascular imaging. 2014 Mar 1; 30(3): 535-41.
[6]	Rachko M, Sa AM, Yeshou D et al: Anterior mitral valve aneurysm: A subaortic complication of aortic valve endocarditis: A case report and review of literature. Heart Disease. 2001; 3: 145-47.
[7]	Gurbuz AS, Ozturk S, Efe SC, Kilicgedik A, Acar E, Karabay CY, Guler A, Kirma C. Perforation of anterior mitral leaflet aneurysm: A rare cause of severe mitral regurgitation. The Egyptian Heart Journal. 2016 Jun 1; 68(2): 131-3.
[8]	Abdulhak AA, Tleyjeh IM. Indications of surgery in infective endocarditis. Current infectious disease reports. 2017 Mar 1; 19(3): 10.
[9]	Gin KG, Boone JA, Thompson CR et al: Conservative management of mitral valve aneurysm. J Am Soc Echocardiogr. 1993; 6: 613-18.
[10]	Vilacosta I, San JR, Sarriá C, Iturralde E, Graupner C, Batlle E, Peral V, Aragoncillo P, Stoermann W. Clinical, anatomic, and echocardiographic characteristics of aneurysms of the mitral valve. The American journal of cardiology. 1999 Jul; 84(1): 110-3.
[11]	Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, Tleyjeh IM. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Global Heart. 2014 Mar 1; 9(1): 131-43.
[12]	Seratnahaei A, Bailey AL, Hensley PJ, O'Connor W, Smith MD. Infective endocarditis complicated by mitral valve aneurysm: pathologic and echocardiographic correlations. Echocardiography. 2015 Sep; 32(9): 1417-22.
[13]	Pena, J.L.B., Bomfim, T.O., Fortes, P.R.L., Simão-Filho, C., and de Souza Andrade-Filho, J. Mitral valve aneurysms: clinical characteristics, echocardiographic abnormalities, and possible mechanisms of formation. Echocardiography. 2017; 34: 986-991.
[14]	Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infectious disease clinics of North America. 1993 Mar; 7(1): 9-19.
[15]	Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, Figueredo VM. Infective endocarditis epidemiology over five decades: a systematic review. PloS one. 2013 Dec 9; 8(12): e82665.
[16]	Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009). The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). European heart journal. 2009 Aug 27; 30(19): 2369-413.
[17]	Raval AN, Menkis AH, Boughner DR. Mitral valve aneurysm associated with aortic valve endocarditis and regurgitation. InHeart Surg Forum 2002 Jan 1 (Vol. 5, pp. 298-299).
[18]	Chu, V.H., Cabell, C.H., Benjamin, D.K. Jr et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004; 109: 1745-1749.
[19]	Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, Valfre C, Olivari Z. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010; 19: 312-320.
[20]	M.R. Movahed, M. Hashemzadeh, M.M. Jamal. Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus. J. Diabetes Complicat., 21 (2007), pp. 403-406.
[21]	B.L. Strom, E. Abrutyn, J.A. Berlin, et al. Risk factors for infective endocarditis: Oral hygiene sand nondental exposures. Circulation, 102 (23) (2000), pp. 2842-2848.
[22]	Colville, T., Sharma, V., & Albouaini, K. (2015). Infective endocarditis in intravenous drug users: a review article. Postgraduate Medical Journal, 92(1084), 105-111.
[23]	Imazio M, Hoit BD. Post-cardiac injury syndromes: an emerging cause of pericardial diseases. Int J Cardiol. 2013; 168: 648-652.
[24]	Imazio M, Brucato A, Rovere ME, Gandino A, Cemin R, Ferrua S, et al. Contemporary features, risk factors, and prognosis of the postpericardiotomy syndrome. Am J Cardiol. 2011; 108: 1183-7.
[25]	van Osch D, Nathoe HM, Jacob KA, Doevendans PA, van Dijk D, Suyker WJ, Dieleman JM. Determinants of the post-pericardiotomy syndrome: a Systematic Review. Eur J Clin Invest. 2017; 47(6): 456-467.